Search for Clinical Trial Results
Lymphoma, B-Cell, Marginal Zone - 25 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Integrated Molecular and Clinical Profiling to Optimize Outcome Prediction in Splenic Marginal Zone Lymphoma Condition: Splenic Marginal Zone Lymphoma Date: 2016-10-23 |
Not yet recruiting |
Study Name: Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Type Condition: MALT Lymphoma Date: 2009-06-17 Interventions: Drug: Lenalidomide 25 mg Lenalidomide p.o. daily for 21 days |
Completed |
Study Name: Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach Condition: Lymphoma Date: 1999-11-01 Interventions:
|
Completed |
Study Name: Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients Condition: MALT Lymphoma Date: 2006-09-07 Interventions: Drug: Thalidomide, Pharmion 200 mg p.o. daily |
Active, not recruiting |
Study Name: R-CVP for the Treatment of Non-conjunctival Ocular Adnexal MALT Lymphoma (OAML) Condition: Lymphoma Date: 2011-08-30 Interventions: Drug: rituximab, cyclophosphamide, vincristine, and prednisolone 6 cycles of R-CVP followed by 2 cycles |